They also noted that HCC tissues from sorafenib-resistant patients exhibited higher intra-tumoral hypoxia and HIF-1α expression than sorafenib-sensitive or untreated HCC tissues [30]. Here, HIF1A is linked to hepatocellular carcinoma.